In this issue of CHEST (see page 1393), Ong et al11 report the pulmonary function and health status at 1 year of a cohort of patients from Singapore who recovered from SARS. There were 206 patients with probable SARS in Singapore, 15% of whom died (32 patients). Of the patients who survived, 46% declined participation, could not be contacted, were underage, or could not perform the battery of tests. The 94 subjects included in this study (half of them were health-care workers) had pulmonary function tests done and the authors administered the St. George’s Respiratory Questionnaire. Unfortunately, exercise testing was not performed. Ong et al11 found that at 1 year, 20 to 30% of the patients had cough, sputum production, or shortness of breath, but the mean values for lung volumes were in the normal range. According to the American Thoracic Society criteria, mild and moderate impairment were present in 32% and 5%, respectively. Only 12% of the study population required admission to the ICUs for severe acute respiratory failure, and only 7% were intubated. Interestingly, the outcomes of the patients with severe respiratory failure were similar to the patients who were not admitted to the ICU. Overall, however, patients who survived SARS had worse health-related quality of life than normal subjects.